Story · Mind & Brain
Alzheimer’s Drug Pipeline: What I Learned at This Year’s CTAD Conference
1 outlet · first reported by Being Patient on
Deborah Kan is the founder and CEO of Being Patient, a journalism-driven news platform on Alzheimer’s, dementia, and brain health that she launched after her mother’s Alzheimer’s diagnosis and years as a journalist for the Wall Street Journal. She built Being Patient to translate complex dementia… (Being Patient)
Coverage, in order
-
Alzheimer’s Drug Pipeline: What I Learned at This Year’s CTAD Conference
Deborah Kan is the founder and CEO of Being Patient, a journalism-driven news platform on Alzheimer’s, dementia, and brain health that she launched after her mother’s Alzheimer’s diagnosis and years as a journalist for the Wall Street Journal. She built Being Patient to translate complex dementia…
Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.